Zobrazeno 1 - 10 of 112 pro vyhledávání: '"Tadashi, Uwagawa"'
1
Akademický článek
The impact of C‐reactive protein‐albumin‐lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy
Autor: Masashi Tsunematsu, Koichiro Haruki, Tomohiko Taniai, Yoshiaki Tanji, Yoshihiro Shirai, Kenei Furukawa, Tadashi Uwagawa, Shinji Onda, Mitsuru Yanagaki, Teruyuki Usuba, Yukio Nakabayashi, Tomoyoshi Okamoto, Toru Ikegami
Publikováno v: Annals of Gastroenterological Surgery, Vol 7, Iss 3, Pp 503-511 (2023)
Abstract Aim The C‐reactive protein (CRP)‐albumin‐lymphocyte (CALLY) index is a novel inflammation‐based biomarker, which has been associated with long‐term outcomes in patients with hepatocellular carcinoma. We aimed to investigate whether
Externí odkaz: https://doaj.org/article/97bcf3a994c84ee5815fbeced2bce8f2
Zobrazit plný text záznamu
2
Akademický článek
Conversion surgery for undifferentiated carcinoma with osteoclast-like giant cells of the pancreas: a case report
Autor: Yosuke Igarashi, Takeshi Gocho, Tomohiko Taniai, Tadashi Uwagawa, Ryoga Hamura, Yoshihiro Shirai, Jungo Yasuda, Koichiro Haruki, Kenei Furukawa, Toru Ikegami
Publikováno v: Surgical Case Reports, Vol 8, Iss 1, Pp 1-5 (2022)
Abstract Background Undifferentiated carcinoma with osteoclast-like giant cells (UCOGCs) is a rare subtype of pancreatic cancer (PC), and its clinicopathological characteristics are still unclear. Herein, we report a case of initially unresectable UC
Externí odkaz: https://doaj.org/article/7c9a4bc3ff594650acfb9b2a7ac0dd24
Zobrazit plný text záznamu
3
Akademický článek
Phase II trial of nafamostat mesilate/gemcitabin/S-1 for unresectable pancreatic cancer
Autor: Tadashi Uwagawa, Taro Sakamoto, Takeshi Gocho, Hiroaki Shiba, Shinji Onda, Jungo Yasuda, Yoshihiro Shirai, Ryoga Hamura, Kenei Furukawa, Katsuhiko Yanaga, Toru Ikegami
Publikováno v: PLoS ONE, Vol 17, Iss 5 (2022)
Purpose To assess the efficacy of combination chemotherapy with nafamostat mesilate, gemcitabine and S-1 for unresectable pancreatic cancer patients. Materials and methods The study was conducted as a single-arm, single center, institutional review b
Externí odkaz: https://doaj.org/article/0ed4599c3a1845c6a50a8d91e2509a65
Zobrazit plný text záznamu
5
Akademický článek
Radical resection of an initially unresectable intrahepatic cholangiocarcinoma after chemotherapy with using gemcitabine, cisplatin, and S-1: report of a case
Autor: Masashi Tsunematsu, Koichiro Haruki, Taro Sakamoto, Tadashi Uwagawa, Hiroaki Shiba, Katsuhiko Yanaga
Publikováno v: Surgical Case Reports, Vol 5, Iss 1, Pp 1-4 (2019)
Abstract Background Metastatic biliary tract cancer (BTC) has poor prognosis. Recently, patients with metastatic BTC who respond well to systemic chemotherapy can be treated by radical resection or “conversion surgery.” Case presentation A 67-yea
Externí odkaz: https://doaj.org/article/c918d04d9d3a40738d845887d96f66f0
Zobrazit plný text záznamu
7
Akademický článek
Nafamostat mesilate, a nuclear factor kappa B inhibitor, enhances the antitumor action of radiotherapy on gallbladder cancer cells.
Autor: Naoki Takada, Hiroshi Sugano, Yoshihiro Shirai, Nobuhiro Saito, Ryoga Hamura, Tomohiko Taniai, Tadashi Uwagawa, Katsuhiko Yanaga, Toru Ikegami, Toya Ohashi, Ken Eto
Publikováno v: PLoS ONE, Vol 16, Iss 9, p e0257019 (2021)
Nuclear factor kappa B (NF-κB) is a transcriptional factor that can be activated by radiotherapy and chemotherapy. The synthetic protease inhibitor nafamostat mesilate (NM) inhibits NF-κB activity and exerts antitumor actions in various types of ca
Externí odkaz: https://doaj.org/article/57ecd7a11fee43a397cbac4cb04ddc4f
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje